Increased expression of centrosomal α, γ-tubulin in atypical ductal hyperplasia and carcinoma of the breast

Cancer Science

Volumn 100, Issue 4, 2009, Pages 580-587

  Niu, Yun ^a   Liu, Tieju ^a   Tse, Gary M K ^b   Sun, Baocun ^a   Niu, Ruifang ^a   Li, Hiu Ming ^b   Wang, Hui ^c   Yang, Yi ^a   Ye, Xue ^c   Wang, Ying ^c   Yu, Qi ^a   Zhang, Fei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; GAMMA TUBULIN; MESSENGER RNA; TUBULIN;

ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST HYPERPLASIA; CARCINOMA IN SITU; CENTROSOME; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DUPLICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC TRANSFORMATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; BREAST TUMOR; FEMALE; GENETICS; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PRECANCER;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CENTROSOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PRECANCEROUS CONDITIONS; TUBULIN;

EID: 67449089091     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.01075.x     Document Type: Article

References (33)

1. Hao XS, Chen KS, Liu H. Analysis of female breast cancer description epidemiology in Tianjin China. Asian Pac J Cancer Prev 2002; 3: 143-8.
2. Delattre M, Gonczy P. The arithmetic of centrosome biogenesis. J Cell Sci 2004; 117: 1619-30.
3. Doxsey S, Zimmerman W, Mikule K. Centrosome control of the cell cycle. Trends Cell Biol 2005; 15: 303-11.
4. Enderling H, Chaplain MA, Anderson AR, Vaidya JS. A mathematical model of breast cancer development, local treatment and recurrence. J Theor Biol 2007; 246: 245-59.
5. Delattre M, Gonczy P. The arithmetic of centrosome biogenesis. J Cell Sci 2004; 117: 1619-30.
6. Salisbury JL, D'Assoro AB, Lingle WL. Centrosome amplification and the origin of chromosomal instability in breast cancer. J Mammary Gland Biol Neoplasia 2004; 9: 275-83.
7. Goepfert TM, Adigun YE, Zhong L, Gay J, Medina D, Brinkley WR. Centrosome amplification and overexpression of aurora a are early events in rat mammary carcinogenesis. Cancer Res 2002; 62: 4115-22.
8. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W. Centrosome amplification drives chromosomal instability in breast tumor development. Cell Biol 2002; 99: 1978-83.
9. Pihan GA, Wallace J, Zhou Y, Doxsey SJ. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 2003; 63: 1398-404.
10. Roh M, Gary B, Song C et al. Overexpression of the oncogenic kinase Pim-1 leads to genomic instability. Cancer Res 2003; 63: 8079-84.
11. Katayama H, Brinkley WR, Sen S. The Aurora kinases: Role in cell transformation and tumorigenesis. Cancer Metastasis Rev 2003; 22: 451-64.
12. Niu Y, Fu XL, Yang X. Research on precancerous lesions and their progression to cancer in breast - report from breast cancer center of Tianjin in China. In:
13. Wu, BQ, ed. Proceedings of the Asia-Pacific International Academy of Pathology Congress IAP, Medimond Via Maserati 5 Bologna Italy: Milan, 2006, 39-43.
14. Niu Y. Pathology Diagnostics of Breast Tumors. Tianjin: Tianjin Science and Technology Publishing House, 2006, 65-7.
15. Niu Y, Liu TJ, Li Y et al. The clinical significance of the expression of four cell cycle regulators in breast papillomotosis. Zhonghua Yi Xue Za Zhi 2003; 83: 1769-73.
16. Niu Y, Wang Y, Wei L, Wei XY, Niu RF. A quantitative immuno-fluorescence analysis of alpha-tubulin and gamma-tubulin proteins in precancerous lesion and carcinoma of the breast and their clinical significance. Zhonghua Zhong Liu Za Zhi 2006; 28: 590-3.
17. Tavassoli FA, Devilee P. The WHO Classification of Tumors of the Breast and Female Genital Organs. Lyon: Editors IARC Press, 2003, 10-12.
18. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 2000; 6: 127-34.
19. Hsu LC, Kapali M, DeLoia JA, Gallion HH. Centrosome abnormalities in ovarian cancer. Int J Cancer 2005; 113: 746-51.
20. Pihan GA, Wallace J, Zhou Y, Doxsey SJ. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 2003; 63: 1398-404.
21. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1999. Int J Epidemiol 2005; 34: 405-12.
22. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. Abnormal centrosome amplification in the absence of p53. Science 1996; 271: 1744-7.
23. Doxsey S, Zimmerman W, Mikule K. Centrosome control of the cell cycle. Trends Cell Biol 2005; 15: 303-11.
24. Kayser G, Gerlach U, Walch A et al. Numerical and structural centrosome aberrations are an early and stable event in the adenoma-carcinoma sequence of colorectal carcinomas. Virchows Arch 2005; 447: 61-5.
25. Löffler H, Lukas J, Bartek J, Krämer A. Structure meets function-centrosomes, genome maintenance and the DNA damage response. Exp Cell Res 2006; 312: 2633-40.
26. Szebenyi G, Hall B, Yu R, Hashim AI, Krämer H. Hook2 localizes to the centrosome, binds directly to centriolin/CEP110 and contributes to centrosomal function. Traffic 2007; 8: 32-46.
27. Schneeweiss A, Sinn HP, Ehemann V et al. Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Int J Cancer 2003; 3: 346-52.
28. Gjerdrum LM, Sorensen BS, Kjeldsen E, Sorensen FB, Nexo E, Hamilton-Dutoit S. Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: An alternative method for HER-2/neu analysis. J Mol Diagn 2004; 6: 42-51.
29. Kulka J, Tôkés AM, Kaposi-Novák P, Udvarhelyi N, Keller A, Schaff Z. Detection of HER-2/neu gene amplification in breast carcinomas using quantitative real-time PCR - a comparison with immunohistochemical and FISH results. Pathol Oncol Res 2006; 12: 197-204.
30. Fukasawa K. Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer 2007; 12: 911-24.
31. Takano T, Hasegawa Y, Miyauchi A et al. overexpression of kalpha1 tubulin mRNA in thyroid anaplastic carcinoma. Cancer Lett 2001; 168: 51-5.
32. Salisbury JL, D'Assoro AB, Lingle WL. Centrosome amplification and the origin of chromosomal instability in breast cancer. J Mammary Gland Biol Neoplasia 2004; 9: 275-83.
33. Pujana MA, Han JD, Starita LM et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Gene 2007; 39: 1338-49.